LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on GPC/SEC from Waters | LabRulez LCMS

    Quantifying quality attributes of AAV gene therapy vectors by SEC-UV-MALS-dRI

    Applications
    | N/A | Wyatt Technology (Waters)
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Agilent Technologies, Waters
    Industries
    Pharma & Biopharma

    Transferring Methods for Monoclonal Antibody Analysis from an Agilent 1260 Infinity Quaternary LC System to an ACQUITY Arc System

    Applications
    | 2016 | Waters
    HPLC, GPC/SEC
    Instrumentation
    HPLC, GPC/SEC
    Manufacturer
    Agilent Technologies, Waters
    Industries
    Pharma & Biopharma

    Size Exclusion Chromatography Method Transfer of a Monoclonal Antibody Across UHPLC Systems

    Applications
    | 2020 | Waters
    HPLC, GPC/SEC
    Instrumentation
    HPLC, GPC/SEC
    Manufacturer
    Agilent Technologies, Waters
    Industries
    Pharma & Biopharma

    Improved Separation Performance of Monoclonal Antibody and Antibody Drug Conjugates Using Waters XBridge Premier Protein SEC 250 Å, 2.5 μm Column

    Applications
    | 2022 | Waters
    Consumables, HPLC, LC columns, GPC/SEC
    Instrumentation
    Consumables, HPLC, LC columns, GPC/SEC
    Manufacturer
    Agilent Technologies, Waters
    Industries
    Pharma & Biopharma
    • Prev
    • 1
    • Next
     

    Related content


    Cal State LA hosts 15th Multidimensional Chromatography Workshop

    Tu, 30.4.2024
    Complex Chemical Composition Analysis Lab (C³AL)

    IOCB Tech has opened Pharmtheon, a high-tech center for new medicines in Prague

    Th, 16.5.2024
    Ústav organické chemie a biochemie AV ČR

    LabRulez CAREER section is waiting for you to open

    We, 15.5.2024
    LabRulez
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike